Upcoming Medical Conferences in Bethesda

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Jan 31, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

Compounding Pharmacy - Aseptic Operations - Option 1 is organized by Parenteral Drug Association (PDA) and will be held from Feb 03 - 05, 2020 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in compounding pharmacy. Departments Quality Control, Pharmacy Roles Supervisor, Analyst, Microbiologist, Pharmacist, Technician Accreditation: CEUs: 1.8 CONTINUING EDUCATION FOR PROFESSIONAL ENGINEERS: New Jersey: The credit value of this course is 18 CPC credits. North Carolina: The credit value of this course is 18 PDH credits. Description: In this training course, you will improve your understanding of microbial control and prevention of cross contamination for better quality compounded preparations. You will gain skills in aseptic technique by participating in hands-on activities such as environmental monitoring, smoke studies, gowning, and aseptic filling of media. Topics will include current issues in compounding pharmacy, cleaning, sterilization and sanitization, and USP <797> and <800>. Objectives: • Demonstrate how to achieve and maintain environmental control • Demonstrate how to achieve sterilization and differentiate from sanitization • Examine use and limitations of unidirectional HEPA filtered air • Explain cleaning and the role of materials of construction • Interpret the revised USP <797> and <800> Additional details will be posted as soon as information is available.

Compounding Pharmacy - Key Concepts in Microbiological Quality Control - Option 1 is organized by Parenteral Drug Association (PDA) and will be held on Feb 07, 2020 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in compounding pharmacy. Departments: Quality Control, Quality Assurance, Quality Systems, Technical Operations, Training Roles: Pharmacist, Auditor, Analyst, Microbiologist, Virologist, Supervisor, Manager Accreditation: CEUs: 0.6 Continuing Education for Professionals Engineers: New Jersey: The credit value of this course is 6 CPC credits. North Carolina: The credit value of this course is 6 PDH credits. Description: Many of the regulations for compounding pharmacies have changed over recent years, with resulting requirements looking more like those applied to pharmaceutical manufacturing. As expectations have evolved so quickly for compounders, there has been a concordant need to quickly learn about new expectations and be prepared to put those into place for day-to-day practice. This training course will help close the knowledge gap about how compounders should be performing their microbiological QC testing, as well as control measures that should be implemented to contribute toward sterility assurance of products. Objectives: • Explain the importance of testing in the overall quality program in the compounding facility • Assess when and what to test when considering microbiological quality of product • Evaluate appropriate methods and equipment to use in microbiological QC testing • Review and interpret micro QC results to examine whether the compounded product is safe and the compounding process and facility is performing as expected • Examine current regulations and how they should be appropriately applied in different compounding settings

2020 American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting is organized by American Society for Experimental Neurotherapeutics (ASENT) and will be held from Mar 02 - 05, 2020 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Description: The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems. Additional details will be posted as soon as they are available.

National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers Course is organized by National Institute on Aging (NIA) and will be held from Mar 24 - 25, 2020 at Natcher Conference Center, Bethesda, Maryland, United States of America.  Description: The goal of the Summit is to bring together individuals with a variety of backgrounds to identify evidence-based programs, strategies, approaches, and other research that can be used to improve the care, services, and supports of persons with dementia and their caregivers.  What types of research are still needed to understand the impact of dementia and improve the care, services, and supports of persons with dementia and their caregivers? This summit differs from other Alzheimer’s disease and related dementias summits as it is focused on research to improve the quality of care and outcomes across care settings, including the lived experience of persons with dementia and their caregivers, rather than on biomedical research or pharmacological interventions. The primary outcome of the Summit is to elicit recommendations for research priorities in these areas to help inform federal agencies, foundations, and private sector organizations. Cross-Cutting Themes • Perspectives from persons with dementia and their caregivers • Health disparities • Ethics • Technology • Etiologies  Additional details will be posted as soon as information is available.

2020 MedStar Genetic Medicine: Pharmacogenomics is organized by MedStar Health and will be held on Apr 04, 2020 at Bethesda Marriott at Pooks Hill, Bethesda, Maryland, United States of America. Target Audience: Anesthesiology, Cardiovascular Disease, Family Medicine, Geriatric Medicine, Internal Medicine, Interventional Cardiology, Medical Genetics and Genomics, Medical Oncology, Oncology, Orthopaedics, Other, Pain Medicine, Pediatrics, Psychiatry Accreditation: This activity was planned by and for the healthcare team, and learners will receive 4.75 Interprofessional Continuing Education (IPCE) credits for learning and change. Description: The program aims to provide an overview of genomic medicine and pharmacogenetics, review specialties where advancements in pharmacogenetics can improve the quality of care, and offer perspective from leading experts in how pharmacogenetics can transform clinical practice. Despite patient and clinician interest in pharmacogenetics, education is often the limiting factor to clinical application. The program will introduce foundational pharmacogenetic concepts, examine clinical evidence, and discuss the translation of evidence to patient care. Attendees will be exposed to a variety of use cases for pharmacogenetics, including pain management, psychiatry, cardiology, and supportive care. Case-based discussions will allow practitioners and healthcare professionals to hear and discuss real-world experiences in using pharmacogenetics in the daily practice of medicine. Objectives: Nurse Learning Objectives: • Summarize foundational concepts related to genomic medicine and pharmacogenetics. • Recall key resources for the clinical application of pharmacogenetics. • Recognize that evidence levels vary between different drug-gene pairs. • Identify clinical scenarios where a genetic result can guide therapy. • Explain how pharmacogenetic results can be used in prescribing decisions. Pharmacist Learning Objectives: • Summarize foundational concepts related to genomic medicine and pharmacogenetics. • Recall key resources for the clinical application of pharmacogenetics. • Recognize that evidence levels vary between different drug-gene pairs. • Identify clinical scenarios where a genetic result can guide therapy. • Explain how pharmacogenetic results can be integrated into pharmacy practice. Physician Learning Objectives: • Summarize foundational concepts related to genomic medicine and pharmacogenetics. • Recall key resources for the clinical application of pharmacogenetics. • Recognize that evidence levels vary between different drug-gene pairs. • Identify clinical scenarios where a genetic result can guide therapy • Explain how pharmacogenetic results can be used in prescribing decisions.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on May 29, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

Compounding Pharmacy - Key Concepts in Microbiological Quality Control - Option 2 is organized by Parenteral Drug Association (PDA) and will be held on Jun 05, 2020 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in compounding pharmacy. Departments: Quality Control, Quality Assurance, Quality Systems, Technical Operations, Training Roles: Pharmacist, Auditor, Analyst, Microbiologist, Virologist, Supervisor, Manager Accreditation: CEUs: 0.6 Continuing Education for Professional Engineers: New Jersey: The credit value of this course is 6 CPC credits. North Carolina: The credit value of this course is 6 PDH credits. Description: Many of the regulations for compounding pharmacies have changed over recent years, with resulting requirements looking more like those applied to pharmaceutical manufacturing. As expectations have evolved so quickly for compounders, there has been a concordant need to quickly learn about new expectations and be prepared to put those into place for day-to-day practice. This training course will help close the knowledge gap about how compounders should be performing their microbiological QC testing, as well as control measures that should be implemented to contribute toward sterility assurance of products. Objectives: • Explain the importance of testing in the overall quality program in the compounding facility • Assess when and what to test when considering microbiological quality of product • Evaluate appropriate methods and equipment to use in microbiological QC testing • Review and interpret micro QC results to examine whether the compounded product is safe and the compounding process and facility is performing as expected • Examine current regulations and how they should be appropriately applied in different compounding settings

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Sep 11, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

2024 ACCP Annual Meeting is organized by American College of Clinical Pharmacology (ACCP) Annual Meeting and will be held from Sep 08 - 10, 2024 at Bethesda North Marriott Hotel & Conference Center, Bethesda, Maryland, United States of America.  Additional details will be posted as soon as they are available.